Literature DB >> 34062314

Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis.

Ekaterina Safroneeva1, Zhaoxing Pan2, Eileen King3, Lisa J Martin4, Margaret H Collins5, Guang-Yu Yang6, Kelley E Capocelli7, Nicoleta C Arva8, J Pablo Abonia9, Dan Atkins10, Peter A Bonis11, Evan S Dellon12, Gary W Falk13, Nirmala Gonsalves14, Sandeep K Gupta15, Ikuo Hirano14, John Leung11, Paul A Menard-Katcher16, Vincent A Mukkada17, Alain M Schoepfer18, Jonathan M Spergel19, Barry K Wershil20, Marc E Rothenberg9, Seema S Aceves21, Glenn T Furuta22.   

Abstract

BACKGROUND & AIMS: Esophageal dilation improves dysphagia but not inflammation in eosinophilic esophagitis (EoE) patients. We investigated if dilation modifies the association between symptoms and peak esophageal eosinophils per high-power field (eos/hpf).
METHODS: Adults enrolled in a multisite prospective Consortium of Gastrointestinal Eosinophilic Disease Researchers Outcome Measures for Eosinophilic Gastrointestinal Diseases Across Ages observational study (NCT02523118) completed the symptom-based EoE activity index (EEsAI) patient-reported outcome instrument and underwent endoscopy with biopsy specimens. Patients were stratified based on dilation status as absent, performed 1 year or less before endoscopy, and performed more than 1 year before endoscopy. Assessments included Spearman correlations of the relationship between symptoms and eos/hpf and linear regression with EEsAI as the outcome, eos/hpf as predictor, and interaction for dilation and eos/hpf.
RESULTS: Among 100 patients (n = 61 males; median age, 37 y), 15 and 40 patients underwent dilation 1 year or less and more than 1 year before index endoscopy, respectively. In nondilated patients, the association between eos/hpf and symptoms was moderate (ρ = 0.49; P < .001); for a 10-eos/hpf increase, the predicted EEsAI increased by 2.69 (P = .002). In patients dilated 1 or less and more than 1 year before index endoscopy, this association was abolished (ρ = -0.38; P = .157 for ≤1 y and ρ = 0.02; P = .883 >1 y); for a 10-eos/hpf increase, the predicted EEsAI changed by -1.64 (P = .183) and 0.78 (P = .494), respectively. Dilation modified the association between symptoms and eos/hpf (P = .005 and P = .187 for interaction terms of eos/hpf and dilation 1 or less years before and more than 1 year before index endoscopy, respectively).
CONCLUSIONS: In nondilated EoE adults, eos/hpf correlate modestly with symptoms; this correlation was no longer appreciated in dilated patients, and the dilation effects lasted longer than 1 year. Dilation status should be considered in studies evaluating EoE treatment and for clinical follow-up evaluation.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  Dysphagia; Effect Modification; Endoscopic Reference Score; Eosinophilic Esophagitis Histologic Scoring System; Eosinophilic Esophagitis-Specific Quality of Life in Adults; Pain When Swallowing

Mesh:

Year:  2021        PMID: 34062314      PMCID: PMC8628021          DOI: 10.1016/j.cgh.2021.05.049

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  16 in total

1.  Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.

Authors:  Alfredo J Lucendo; Stephan Miehlke; Christoph Schlag; Michael Vieth; Ulrike von Arnim; Javier Molina-Infante; Dirk Hartmann; Albert Jan Bredenoord; Constanza Ciriza de Los Rios; Stefan Schubert; Stefan Brückner; Ahmed Madisch; Jamal Hayat; Jan Tack; Stephen Attwood; Ralph Mueller; Roland Greinwald; Alain Schoepfer; Alex Straumann
Journal:  Gastroenterology       Date:  2019-03-26       Impact factor: 22.682

2.  Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis.

Authors:  T M Runge; S Eluri; J T Woosley; N J Shaheen; E S Dellon
Journal:  Dis Esophagus       Date:  2017-07-01       Impact factor: 3.429

3.  The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life.

Authors:  T H Taft; E Kern; M A Kwiatek; I Hirano; N Gonsalves; L Keefer
Journal:  Aliment Pharmacol Ther       Date:  2011-08-02       Impact factor: 8.171

4.  Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.

Authors:  Ikuo Hirano; Evan S Dellon; Jennifer D Hamilton; Margaret H Collins; Kathryn Peterson; Mirna Chehade; Alain M Schoepfer; Ekaterina Safroneeva; Marc E Rothenberg; Gary W Falk; Yehudith Assouline-Dayan; Qiong Zhao; Zhen Chen; Brian N Swanson; Gianluca Pirozzi; Leda Mannent; Neil M H Graham; Bolanle Akinlade; Neil Stahl; George D Yancopoulos; Allen Radin
Journal:  Gastroenterology       Date:  2019-10-05       Impact factor: 22.682

5.  Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration.

Authors:  Sandeep K Gupta; Gary W Falk; Seema S Aceves; Mirna Chehade; Margaret H Collins; Evan S Dellon; Nirmala Gonsalves; Ikuo Hirano; Vincent A Mukkuda; Kathryn A Peterson; Jonathan Spergel; Guang-Yu Yang; Glenn T Furuta; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2018-11-17       Impact factor: 22.682

6.  Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation.

Authors:  Alain M Schoepfer; Nirmala Gonsalves; Christian Bussmann; Sébastien Conus; Hans-Uwe Simon; Alex Straumann; Ikuo Hirano
Journal:  Am J Gastroenterol       Date:  2009-11-24       Impact factor: 10.864

7.  Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

Authors:  Alain M Schoepfer; Alex Straumann; Radoslaw Panczak; Michael Coslovsky; Claudia E Kuehni; Elisabeth Maurer; Nadine A Haas; Yvonne Romero; Ikuo Hirano; Jeffrey A Alexander; Nirmala Gonsalves; Glenn T Furuta; Evan S Dellon; John Leung; Margaret H Collins; Christian Bussmann; Peter Netzer; Sandeep K Gupta; Seema S Aceves; Mirna Chehade; Fouad J Moawad; Felicity T Enders; Kathleen J Yost; Tiffany H Taft; Emily Kern; Marcel Zwahlen; Ekaterina Safroneeva
Journal:  Gastroenterology       Date:  2014-08-23       Impact factor: 22.682

8.  Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis.

Authors:  Ekaterina Safroneeva; Alex Straumann; Michael Coslovsky; Marcel Zwahlen; Claudia E Kuehni; Radoslaw Panczak; Nadine A Haas; Jeffrey A Alexander; Evan S Dellon; Nirmala Gonsalves; Ikuo Hirano; John Leung; Christian Bussmann; Margaret H Collins; Robert O Newbury; Giovanni De Petris; Thomas C Smyrk; John T Woosley; Pu Yan; Guang-Yu Yang; Yvonne Romero; David A Katzka; Glenn T Furuta; Sandeep K Gupta; Seema S Aceves; Mirna Chehade; Jonathan M Spergel; Alain M Schoepfer
Journal:  Gastroenterology       Date:  2015-11-14       Impact factor: 22.682

9.  AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.

Authors:  Ikuo Hirano; Edmond S Chan; Matthew A Rank; Rajiv N Sharaf; Neil H Stollman; David R Stukus; Kenneth Wang; Matthew Greenhawt; Yngve T Falck-Ytter
Journal:  Gastroenterology       Date:  2020-05       Impact factor: 33.883

10.  Dilation Modifies Association Between Symptoms and Esophageal Eosinophilia in Adult Patients With Eosinophilic Esophagitis.

Authors:  Ekaterina Safroneeva; Cary C Cotton; Alain M Schoepfer; Marcel Zwahlen; John T Woosley; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2020-12       Impact factor: 12.045

View more
  2 in total

1.  A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.

Authors:  Evan S Dellon; Paneez Khoury; Amanda B Muir; Chris A Liacouras; Ekaterina Safroneeva; Dan Atkins; Margaret H Collins; Nirmala Gonsalves; Gary W Falk; Jonathan M Spergel; Ikuo Hirano; Mirna Chehade; Alain M Schoepfer; Calies Menard-Katcher; David A Katzka; Peter A Bonis; Albert J Bredenoord; Bob Geng; Elizabeth T Jensen; Robert D Pesek; Paul Feuerstadt; Sandeep K Gupta; Alfredo J Lucendo; Robert M Genta; Girish Hiremath; Emily C McGowan; Fouad J Moawad; Kathryn A Peterson; Marc E Rothenberg; Alex Straumann; Glenn T Furuta; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2022-05-20       Impact factor: 14.290

2.  A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.

Authors:  Evan S Dellon; Paneez Khoury; Amanda B Muir; Chris A Liacouras; Ekaterina Safroneeva; Dan Atkins; Margaret H Collins; Nirmala Gonsalves; Gary W Falk; Jonathan M Spergel; Ikuo Hirano; Mirna Chehade; Alain M Schoepfer; Calies Menard-Katcher; David A Katzka; Peter A Bonis; Albert J Bredenoord; Bob Geng; Elizabeth T Jensen; Robert D Pesek; Paul Feuerstadt; Sandeep K Gupta; Alfredo J Lucendo; Robert M Genta; Girish Hiremath; Emily C McGowan; Fouad J Moawad; Kathryn A Peterson; Marc E Rothenberg; Alex Straumann; Glenn T Furuta; Seema S Aceves
Journal:  Gastroenterology       Date:  2022-05-20       Impact factor: 33.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.